Virtus Investment Advisers’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-63,278
Closed -$973K 465
2025
Q4
$973K Buy
63,278
+20,548
+48% +$226K 0.26% 133
2025
Q3
$424K Hold
42,730
0.12% 220
2025
Q2
$424K Buy
42,730
+15,094
+55% +$159K 0.14% 218
2025
Q1
$358K Buy
+27,636
New +$366K 0.1% 224
2023
Q1
Sell
-10,147
Closed -$108K 296
2022
Q4
$108K Hold
10,147
0.07% 267
2022
Q3
$106K Buy
+10,147
New +$132K 0.05% 286

Other funds holding DVAX

Virtus Investment Advisers's DVAX Position: Q1 2026 in Review

Virtus Investment Advisers sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 63,278 shares — an estimated $973K sold.

Virtus Investment Advisers first reported a position in DVAX in Q3 2022 and held it in 6 quarters. The position peaked at $973K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Virtus Investment Advisers reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Virtus Investment Advisers sold 63,278 Dynavax Technologies shares in Q1 2026, an estimated $973K.
  • Virtus Investment Advisers first reported a position in Dynavax Technologies in Q3 2022 and held it in 6 quarters.
  • Virtus Investment Advisers's Dynavax Technologies position peaked at $973K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.